1. Risk of Hepatocellular Carcinoma after HCV Clearance by Direct-Acting Antivirals Treatment Predictive Factors and Role of Epigenetics
   Luca Rinaldi et al, 2020, Cancers CrossRef
2. Hepatocellular carcinoma after direct-acting antiviral hepatitis C virus therapy: A debate near the end
   Cristina Maria Muzica et al, 2020, WJG CrossRef
3. Increased Visceral Adipose Tissue and Hyperinsulinemia Raise the Risk for Recurrence of Non-B Non-C Hepatocellular Carcinoma after Curative Treatment
   Kenji Imai et al, 2021, Cancers CrossRef
4. Impact of successful HCV treatment using direct acting antivirals on recurrence of well ablated hepatocellular carcinoma
   Tamer Elbaz et al, 2021, Expert Review of Anti-infective Therapy CrossRef
5. Predictive Factors for Hepatocellular Carcinoma Development after Direct-Acting Antiviral Treatment of HCV
   Zuzana Macek Jilkova et al, 2021, Livers CrossRef
6. Association between direct-acting antiviral agents in hepatitis C virus treatment and hepatocellular carcinoma occurrence and recurrence: The endless debate
   Ahmed Kamal et al, 2022, WJCC CrossRef
7. Efficacy of hepatitis C virus eradication after curative treatment for hepatocellular carcinoma in patients with advanced hepatocellular carcinoma and decreased hepatic functional reserve: A nationwide, multicentre study by the Japanese Red Cross Liver Study Group
   Toshie Mashiba et al, 2022, Journal of Viral Hepatitis CrossRef
8. null
   Utz Settmacher et al, 2023 CrossRef
9. Hepatitis C Virus-Related One-Year Hepatocellular Carcinoma Recurrence After Directly Acting Antivirals: A Randomized Controlled Trial
   Ahmed Kamal et al, 2024, J Gastrointest Canc CrossRef